XOMA Royalty Corp. (XOMA)
41.82
-0.16
(-0.38%)
USD |
NASDAQ |
May 21, 16:00
41.85
+0.03
(+0.07%)
After-Hours: 19:59
XOMA Royalty Research and Development Expense (TTM) : 0.468M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ligand Pharmaceuticals, Inc. | 33.24M |
| Galera Therapeutics, Inc. | 0.271M |
| Organon & Co. | 363.00M |
| Rezolute, Inc. | 59.77M |
| Outlook Therapeutics, Inc. | 19.68M |